Interfering Factors in the Assay of Plasminogen Activators by the Fibrin Plate Method

Summary

The assay of plasminogen activator activities on fibrin plates was re-evaluated with special reference to fibrinolysis inhibitors present in samples and in fibrin plates. The nature, action and stability of inhibiting material were studied in tissues with considerable differences in activator and inhibitor contents! human lung, liver and placenta. Extracts were tested for inhibitory capacity against purified human uterine tissue plasminogen activator, urokinase and plasmin on fibrin plates prepared from different grades of fibrinogens and fibrin.

The tissue extracts inhibited fibrinolysis on fibrin plates to varying degrees, dependent on the sample medium, the type of fibrin plate and the kind of plasminogen activator. The influence of inhibitors in the sample and in the fibrin plate was partly abolished by the presence of 2 M KSCN in the sample. The procedure for preparing the samples as described by Astrup and Albrechtsen did not completely eliminate the inhibitory action against the added plasminogen activators.

Comparison of urokinase inhibition with tissue activator inhibition by the tissue extracts as to the degree of denaturation in the Astrup and Albrechtsen procedure showed that they have much in common. Nevertheless, some differences were found which indicated the possible existence of separate urokinase and tissue activator inhibitors or of different inhibition mechanisms for these plasminogen activators.

• References

• 1 Albrechtsen OK. 1956; The fibrinolytic activity of the endometrium. Acta Endocrinologica 23: 207
• 2 Albrechtsen OK. 1957; The fibrinolytic activity of human tissues. British Journal of Haematology 3: 284
• 3 Astrup T. 1966; Tissue activators of plasminogen. Federation Proceedings 25: 42
• 4 Astrup T. 1969. Fibrinolytic mechanism in man and animals. In: Johnson SA, and Mason GUESTM. (eds.) Dynamics in Thrombus Formation and Dissolution. J. B. Lippincott Company; Philadelphia and Toronto: p 275
• Astrup T, Albrechtsen OK. 1957; Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scandinavian Journal of Clinical and Laboratory Investigation 9: 233
• 6 Astrup T, Albrechtsen OK, Claasson M, Rasmussen J. 1959; Thromboplastic and fibrinolytic activity of the human aorta. Circulation Research 7: 969
• 7 Astrup T, Mullertz S. 1952; The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics 40: 346
• 8 Astrup T, Permin PM. 1947; Fibrinolysis in the animal organism. Nature (London) 159: 681
• 9 Astrup T, Stage A. 1952; Isolation of a soluble fibrinolytic activator from animal tissue. Nature (London) 170: 929
• 10 Brakman P, Astrup T. 1971. The fibrin plate method for assay of fibrinolytic agents. In: Bang NU, Beller FK, Deutsch E, Mammen EF. (eds.) Thrombosis and Bleeding Disorders. Academic Press; New York: p 332
• 11 Bernik MB, Kwaan HC. 1971; Inhibitors of fibrinolysis in human tissues in culture. American Journal of Physiology 221: 916
• 12 Haverkate F, Brakman P. 1975. Fibrin plate assay. In: Davidson JF, Samama MM, Desnoyers PC. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 1.. Raven Press; New York: p 151
• 13 Haverkate F, Timan G. 1976. Preparation of highly purified bovine fibrin plates. In: Davidson JF, Samama MM, Desnoyers PC. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 2.. Raven Press; New York: p 67
• 14 Hisazumi H. 1973; Inhibitory effect of normal and cancerous tissues of the bladder on plasminogen activation. Investigative Urology 11: 258
• 15 Kawano T, Morimoto K, Uemura Y. 1968; Urokinase inhibitor in human placenta. Nature (London) 217: 253
• 16 Kawano T, Uemura Y. 1971; Inhibition of tissue activator by urokinase inhibitor. Thrombosis et Diathesis Haemorrhagica 25: 129
• 17 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265
• 18 Macfarlane RG, Biggs R. 1948; Fibrinolysis.Its mechanism and significance. Blood 3: 1167
• 19 Moltke P. 1958; Plasminogen activator in animal meninges. Proceedings of the Society for Experimental Biology and Medicine 98: 377
• 20 Noordhoek Hegt V, Brakman P. 1974; Histochemical study of an inhibitor of fibrinolysis in the human arterial wall. Nature (London) 248: 75
• 21 Noordhoek Hegt V, Brakman P. 1975. Histochemical demonstration of inhibition of fibrinolysis in human tissues by means of the fibrin slide sandwich technique. In: Davidson JF, Samama MM, Desnoyers PC. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 1.. Raven Press; New York: p 229
• 22 Pandolfi M, Coccheri S, Astrup T. 1962; Thromboplastic and fibrinolytic activities in tissues of the eye. Proceedings of the Society for Experimental Biology and Medicine 109: 159
• 23 Pugath EM J, Foster EA, Macfarlane DE, Poole JC F. 1970; The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mesothelium. British Journal of Haematology 18: 669
• 24 Todd AS. 1959; The histological localization of fibrinolysin activator. Journal of Pathological Bacteriology 78: 281
• 25 Todd AS. 1960. The tissue activator of plasminogen and thrombosis. In: WALKER W. (ed.) Thrombosis and Anticoagulant Therapy. Livingstone Ltd; London: p 15
• 26 Uszynski M, Abildgaard U. 1971; Separation and characterization of two fibrinolytic inhibitors from human placenta. Thrombosis et Diathesis Haemorrhagica 25: 580
• 27 Uszynski M, Uszynski-Folejewska R. 1969; Plasminogen activator and urokinase inhibitor in myometrium, placenta and amniotic fluid. American Journal of Obstetrics and Gynecology 105: 1041